"An Intermediate Size Patient Population Expanded Access Protocol to Evaluate the Safety and Efficacy of Allogeneic HB-adMSCs (Hope Biosciences - Adipose Derived Mesenchymal Stem Cells) for the Treatment of Multiple System Atrophy."

NCT07238062 · clinicaltrials.gov ↗

AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Multiple System Atrophy

Interventions

BIOLOGICAL: HB-adMSCs - Hope Biosciences Adipose Derived Mesenchymal Stem Cells

Sponsor

Hope Biosciences Research Foundation